Another liposomal vaccine combining PADRE with HER2/neu-derived peptides AE36 and E75 resulted in a reduction of tumor growth via induction of potent CD8+ T cell responses in a mouse model for breast cancer [207]. Here, ERBB2 is linked to breast carcinoma.